Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study
CONCLUSION: ICI-treated patients may exhibit a higher risk of ATEs, especially after 1 year of treatment.PMID:37584246 | DOI:10.1002/cam4.6455
Source: Atherosclerosis - Category: Cardiology Authors: Jie Zhu Yue Chen Yuanlong Zhang Wei Wang Yujue Wang Zhuo Lu Yulin Zhang Haike Lei Dairong Li Bo Long Haixia Liu Source Type: research
More News: Atrial Fibrillation | Cancer | Cancer & Oncology | Cardiology | Diabetes | Endocrinology | Heart | Heart Disease | Hypertension | Ischemic Stroke | Stroke | Study | Thrombosis